Table 1.
Patients’ characteristics grouped by LDL‐C goal achievement or not
| Characteristics | Result (n, %) | |||
|---|---|---|---|---|
| Total (n = 3956) | With LDL‐C goal achievement (n = 1082) | Without LDL‐C goal achievement (n = 2874) | ||
| Gender | Male, n (%) | 2696 (68.15%) | 796 (73.57%) | 1900 (66.11%) |
| Age (year) | ≥18,≤45 | 179 (4.52%) | 58 (5.36%) | 121 (4.21%) |
| ≥46,≤65 | 1956 (49.44%) | 524 (48.43%) | 1432 (49.83%) | |
| ≥66,≤75 | 1014 (25.63%) | 266 (24.58%) | 748 (26.03%) | |
| ≥76 | 798 (20.17%) | 232 (21.44%) | 566 (19.69%) | |
| Unknown | 9 (0.23%) | 2 (0.18%) | 7 (0.24%) | |
| Race | Han | 3921 (99.12%) | 1071 (99.00%) | 2850 (99.16%) |
| Others | 35 (0.88%) | 11 (1.00%) | 24 (0.84%) | |
| Education | College and above | 392 (9.9%) | 112 (10.4%) | 280 (9.7%) |
| High school | 1047 (26.5%) | 295 (27.3%) | 752 (26.2%) | |
| Middle school | 1145 (28.9%) | 312 (28.8%) | 833 (29.0%) | |
| Primary school | 878 (22.2%) | 239 (22.1%) | 639 (22.2%) | |
| Illiteracy | 313 (7.9%) | 98 (9.1%) | 215 (7.5%) | |
| Unknown | 181 (4.6%) | 26 (2.4%) | 155 (5.4%) | |
| Smokinga | Never | 2048 (51.77%) | 548 (50.64%) | 1500 (52.19%) |
| Current | 799 (20.20%) | 330 (30.50%) | 759 (26.41%) | |
| Past | 1089 (27.53%) | 198 (18.30%) | 601 (20.91%) | |
| Unknown | 20 (0.5%) | 6 (0.55%) | 14 (0.49%) | |
| Alcohol intakeb | Yes | 950 (24.01%) | 282 (26.06%) | 668 (23.24%) |
| No | 2955 (74.7%) | 783 (72.37%) | 2172 (75.57%) | |
| Unknown | 51 (1.29%) | 17 (1.57%) | 34 (1.19%) | |
| Physical activityc | ≤1/week | 1378 (34.83%) | 380 (35.12%) | 998 (34.73%) |
| 2–3/week | 977 (24.70%) | 277 (25.60%) | 700 (24.36%) | |
| ≥3/week | 1499 (37.89%) | 386 (35.67%) | 1113 (38.73%) | |
| Unknown | 102 (2.58%) | 39 (3.60%) | 63 (2.19%) | |
| CVDd | Yes | 747 (18.88%) | 187 (17.28%) | 560 (19.49%) |
| No | 2967 (75.00%) | 837 (77.36%) | 2130 (74.11%) | |
| Unknown | 242 (6.12%) | 58 (5.36%) | 184 (6.40%) | |
| TIAd | Yes | 256 (6.47%) | 73 (6.75%) | 183 (6.37%) |
| Once | 138 (3.49%) | 36 (3.33%) | 102 (3.55%) | |
| 2 times | 48 (1.21%) | 16 (1.48%) | 32 (1.11%) | |
| ≥3 times | 70 (1.77%) | 21 (1.94%) | 49 (1.70%) | |
| No | 3612 (91.30%) | 989 (91.40%) | 2623 (91.27%) | |
| Unknown | 88 (2.22%) | 20 (1.85%) | 68 (2.37%) | |
| Carotid artery stenosis | Yes | 956 (24.17%) | 269 (24.86%) | 687 (23.90%) |
| No | 2639 (66.71%) | 747 (69.04%) | 1892 (65.83%) | |
| Unknown | 361 (9.13%) | 66 (6.10%) | 295 (10.26%) | |
| CADd | Yes | 786 (19.87%) | 198 (18.30%) | 588 (20.46%) |
| No | 3071 (77.63%) | 866 (80.04%) | 2205 (76.72%) | |
| Unknown | 99 (2.50%) | 18 (1.66%) | 81 (2.82%) | |
| Hypertension | Yes | 3058 (77.30%) | 851 (78.65%) | 2207 (76.79%) |
| No | 881 (22.27%) | 230 (21.26%) | 651 (22.65%) | |
| Unknown | 17 (0.43%) | 1 (0.09%) | 16 (0.56%) | |
| Diabetes | Yes | 1210 (30.59%) | 346 (31.98%) | 864 (30.06%) |
| No | 2729 (68.98%) | 732 (67.65%) | 1997 (69.49%) | |
| Unknown | 17 (0.43%) | 4 (0.37%) | 13 (0.45%) | |
| Dyslipidemia | Yes | 2044 (51.67%) | 472 (43.62%) | 1572 (54.70%) |
| No | 1911 (48.31%) | 610 (56.38%) | 1301 (45.27%) | |
| Unknown | 1 (0.03%) | 0 (0.00%) | 1 (0.03%) | |
| Type of stroke | Cerebral infarction | 3955 (99.97%) | 1082 (100%) | 2873 (72.62%) |
| Intracerebral hemorrhage | 83 (2.10%) | 29 (2.68%) | 54 (1.37%) | |
| Subarachnoid brain hemorrhage | 1 (0.03%) | 0 (0.00%) | 1 (0.03%) | |
| Time from stroke onset | n (missing) | 3956 (0) | 1082 (0) | 2874 (0) |
| Mean ± SD (day) | 275.1 ± 55.5 | 269.62 ± 55.77 | 277.15 ± 55.27 | |
| Median (min, max) | 274 (182, 366) | 265.00 (183, 366) | 278.00 (182, 366) | |
| Lipid‐lowering drugs | Statins | 3072 (77.65%) | 967 (89.37%) | 2105 (73.24%) |
| Fibrates | 25 (0.63%) | 6 (0.55%) | 19 (0.66%) | |
| Cholesterol absorption inhibitor | 24 (0.61%) | 8 (0.74%) | 16 (0.56%) | |
| Nicotinic acid and its derivatives | 1 (0.03%) | 0 (0.00%) | 1 (0.03%) | |
| Others | 79 (2.00%) | 14 (1.29%) | 65 (1.26%) | |
| Anticoagulant | Yes | 203 (5.1%) | 77 (7.1%) | 126 (4.4%) |
| No | 3753 (94.9%) | 1005 (92.9%) | 2748 (95.6%) | |
| Antihypertension | Yes | 2691 (68.0%) | 756 (69.9%) | 1935 (67.3%) |
| No | 1265 (32.08%) | 326 (30.1%) | 939 (32.7%) | |
| Antidiabetes | Yes | 1048 (26.5%) | 303 (28.0%) | 745 (25.9%) |
| No | 2908 (73.5%) | 779 (72.0%) | 2129 (74.1%) | |
| Medication compliance | Never missed | 2389 (60.39%) | 796 (73.56%) | 1593 (55.43%) |
| Rarely (missed ≤once/week) | 459 (11.60%) | 137 (12.66%) | 322 (11.20%) | |
| Occasionally (missed 2–3 times/week) | 151 (3.82%) | 17 (1.57%) | 133 (4.63%) | |
| Frequently (missed≥ 4 times/week) | 150 (3.79%) | 28 (2.59%) | 123 (4.28%) | |
| LDL‐C | 2.42 ± 0.91 mmol/L | 1.42 ± 0.27 mmol/L | 2.79 ± 0.77 mmol/L | |
a
Smoking at least one cigarette per day with a total duration of at least 6 months.
b
Drinking (white wine, red wine, millet wine, or beer) at 3 drinks per week with a total duration of at least 6 months.
c
30 min or more each time.
d
Abbreviations: CAD, coronary artery disease; TIA, transient ischemic attack; CAD, coronary artery disease.